WO1987005503A1 - Cosmetic compositions and process for preparing the same - Google Patents
Cosmetic compositions and process for preparing the same Download PDFInfo
- Publication number
- WO1987005503A1 WO1987005503A1 PCT/HU1987/000012 HU8700012W WO8705503A1 WO 1987005503 A1 WO1987005503 A1 WO 1987005503A1 HU 8700012 W HU8700012 W HU 8700012W WO 8705503 A1 WO8705503 A1 WO 8705503A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metal ion
- metal
- acid
- components
- ion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
Definitions
- the present invention relates to a process for preparing biologieally active ligancs and metal ion-ligand complexes as well as to cosmetic preparations comprising metal ions or metal ion complexes.
- Cosmetic compositions of different types have always been used during history. These serve mainly for retaining and enhancing the elasticity and freshness of ageing skin.
- the first cosmetics were vegetable oils which later were transformed to emulsions
- oils and fats likeoliveoil, peanut oil, seal oil, cod-liver oil, etc.
- compositions also contain so-called "active agents" which are added to the aqueous or the oil phase.
- active ingredients are added in order to keep the ageing skin fresh intensively.
- active ingredients include e. g. vitamines, such as A, B, D, E, K, F, panthotenic acid, and the like, provitamines, such as beta-carotine, Riper-complex, proteins, vegetable extracts, extract of sea living organisms, including algae, etc.
- active ingredients include e. g. vitamines, such as A, B, D, E, K, F, panthotenic acid, and the like, provitamines, such as beta-carotine, Riper-complex, proteins, vegetable extracts, extract of sea living organisms, including algae, etc.
- medicines may also be mixed to the creams, i. e. some medicines are also present in the form of cream. This form of medicine is especially desired if it should be administered intradermally.
- These creams may contain antiphlogistica
- Chlorocid-H R Chlorocid-H R , Tetran R , etc.
- antiall ergistic agents such as
- Prednisolon-J R Locoid R , Kydrocortison R , Nicoflex R , antirheumatic drugs, such as Bayolin R , Phogosam R , Arthrofluor R , etc.
- side effects can also appear, most of which being non-desired. These side effects are especially frequent in case of an ti rheumatic compositions, see
- the enzymes are special proteins of the human organism and act as catalyst. For the proper action thereof metal ions are also essential.
- Such enzymes include e. g. the metallo-enzymes, such as carbonic acid anhydrace /Zn/, methylmalonyl-CoA-mutase /Co/, xanthine oxidase /Mo/, the metallic ion activated enzymes, such as arginase /Mn/, acylase /Zn/, etc.
- Certain metals having more valence state play an important role in the redox reactions /Fe, Cu, Mo, Co, V, Cr, Sn/, see e. g. Friedem M.: Protein-Metall Interaction, "Advances in Experimental Medicine and Biology " Vol. 48, Plenum Press, New York, 1974.
- the mechanism of uptake of metal»ions is as follows: in the first step either the metal ion is bound to the surface or a complex forming ligandum /L/ reacts with the metal ion:
- metal ion penetrates into the biological system, e. g. by permeating the cell membrane and/or the oxidation degree of the metal might also be changed and finally reaches the active centre of the protein in the form of ML 1 or ML 2 , see Frusta da Siliva, Williams, R. J. P.: The Uptake of Elements by Biological Systems, Structure and Bonding, 29, 67/1977.
- metals are more active in their reduced state, such as Fe 2+ , Mo 3+ , Cr 2+ , Vc 2 + , etc.
- metal ions are of vital importance for the organism.
- the ability of organism to uptak the same depends to agreat extent on the surrounding, as well as on the internal conditions.
- the most important characteristics in this respect are the pH, ion strength, redox potential, the chemical environment and the like.
- the present invention provides a process for preparing ciollogically active ligands from plant material containing histones.
- Another object of the invention is the preparation of iologically acvive ion-ligani complexes by the reaction of plant histone hydrolisates and metal salts.
- Another object of the present invention is a cosmetic composition, characterized by consisting of at least two components wherein each of the components contains at least one metal ion or metal ion complex, at least one of the components contains the metal in the lowest oxidation degree thereof, the said metal ions or metal ion complexes of the individual components forming a galvanic chain and being non-reactive with each other.
- the present invention provides a process for introducing metel ions into the organism through the skin while providing an optimal pH,ion strength, redox potential and chemical environment /ligandum/.
- the novel body care composition of the present invention not only performs the hydratization and thus refreshing and softening the skin, but also regenerates the complete organism due to the electric and bioactive effect thereof. Thus, refreshment of the entire body will be obtained and the pains caused by certain ach ing body parts will be reduced and eliminated, respectively.
- the ligands bound to metal ions used according to the present invention can preferably be handled at a pH value of 5 to 6 and the preparation of creams and body care compositions can be accomplished easily by using the same. An ion strength of 0,3 may easily be maintained when preparing the compositions with tap water of .sufficient purity.
- the essence of the invention is the formation of the redox system. According to the present invention the redox system is established by dividing the metal ions of varying valence so that they form a galvanic element by acting as redox electrodes. Examples of the molecular galvanic chain to be used according to the invention are as follows:
- the complete galvanic chain may not be present within the same cream, as the equilibrium would set in in a very short period due to discharge.
- one of the electrodes /in the present example Au//SnCl 2 + SnCl 4 / should be present in a first cream, while the other electrode /Au//FeCl 3 + FeCl 2 / should be incorporated in an other cream.
- the redox reaction which by all probability also includes the exchange of ligands, takes place in the lower layers of skin and provides a preferred curative effect.
- the electrodes of the aforesaid galvanic chains are separated from each other by incorporating the same into divided units /cream A, B/. More than two galvanic chain members can also be prepared of course, in this case more than two divided units should be prepared /A, B, C, etc./.
- An example of a three-components composition is the following:
- the ligands used according to the present invention can be prepared by hydrolyzing suitable histones.
- suitable histones such as beets, see J. R. Hafferl, W. Sci. Pharm.27, 230 /1959/, mistletoe, see Belgian Patent No. 646095 and the like had already been known.
- By separating and subsequently hydrolizing the extracts polipeptyde chains of good complex forming ability may be obtained.
- the liquor thus obtained is centrifuged and dried.
- the crude extract thus obtained is purified by chromatography.
- cation exchange resins such as IRC-50 R , Dowex 50W R , DEAE cellulose and the like or adsorption resins, such as Amberlite XAD-2 R ,
- DiaionHP-20 R and the like may be used.
- the purified products are transformed to acid addition salt thereof formed by organic acids and then hydrolized at 120 to 150 °C for 1 to 10 hours.
- the proce ss de scribed in example 1 was followed with the difference that the crude product obtained was purified on an adsorption re sin instead of the cation exchanger.
- 10 g of fumaric acid we re added and dis solved in 100 ml of water and subsequently 30 ml of acetone were added to the solution.
- the mixture was applied on 5 x 80 cm chromatography column packed with XAD -2 R re sin pre -treated with a mixture of water and acetone /40:50/.
- the column was eluted with water-acetone mixtures containing descending amount of acetone .
- the protein-containing fractions were combined and evaporated in vacuo to 1 /20 of the original volume .
- the concentrate was hydroiized at 110 °C for 5 hours and dried in vacuo , thus obtaining 14, 5 g product .
- TWEEN-60 R The emulsion was cooled to ambient temperature while stirring.
- Example 5 Body care composition containing metal ion-ligand complex
- the pH of the solution thus obtained was adjusted to 5,5 and then mixed at 70 oC with the fatty phase consisting of the following ingredients: 70 g of stearyl-monogiyceride, 70 g of white vaseline, 82 g of cetyl alcohol, 30 g of maize oil, 30 g of TWEEN-60 R and 0,2 g of butyl-hydroxy toluene.
- the emulsion was cooled to ambient temperature while stirring.
- Example 6 Body care jelly containing metal ion-ligand complex
- Carbopol-940 R were swelled in 700 ml of tap water, the two solutions were combined and the jelly was prepared by the addition of 13 g of triethanol amine.
- Carbopol-940 R were swelled in 700 ml of tap water, the two solution were combined and the jelly was prepared by the addition of 13 g of triethanol amine .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO874656A NO874656D0 (en) | 1986-03-11 | 1987-11-09 | COSMETIC PREPARATIONS AND PROCEDURES IN THEIR PREPARATION. |
DK587987A DK587987D0 (en) | 1986-03-11 | 1987-11-10 | PROCEDURE FOR MANUFACTURING BIOLOGICALLY ACTIVE LIGANDS AND COSMETIC PREPARATION CONTAINING THESE LIGANDS |
FI884143A FI884143A0 (en) | 1986-03-11 | 1988-09-09 | KOSMETISKA SAMMANSAETTNINGAR SAMT FOERFARANDE FOER FRAMSTAELLNING DAERAV. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1013/86 | 1986-03-11 | ||
HU101386 | 1986-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1987005503A1 true WO1987005503A1 (en) | 1987-09-24 |
Family
ID=10952457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU1987/000012 WO1987005503A1 (en) | 1986-03-11 | 1987-03-11 | Cosmetic compositions and process for preparing the same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0296173A1 (en) |
JP (1) | JPH01502428A (en) |
FI (1) | FI884143A0 (en) |
WO (1) | WO1987005503A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042082A1 (en) * | 1998-02-23 | 1999-08-26 | Pierre Fabre Dermo-Cosmetique | Cosmetic composition comprising minor elements derived from mineral waters and chelated by plant protein hydrolysates |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1003919B (en) * | 1954-10-04 | 1957-03-07 | Ernst Sieckmann | Process for the preparation of a skin care agent |
BE646095A (en) * | 1963-04-04 | 1964-10-05 | ||
CH551195A (en) * | 1969-01-23 | 1974-07-15 | Prephar | COSMETIC PREPARATIONS. |
WO1984000298A1 (en) * | 1982-07-16 | 1984-02-02 | Koezponti Valto Hitelbank | Method for producing compositions having a relaxing effect and fixed to the skin |
FR2546754A1 (en) * | 1983-06-03 | 1984-12-07 | Caola Kozmetikai | COSMETIC AGENTS FOR THE CARE OF HEALTH AND BODY |
EP0155344A2 (en) * | 1983-08-02 | 1985-09-25 | Blendax GmbH | Skin treatment composition |
-
1987
- 1987-03-11 WO PCT/HU1987/000012 patent/WO1987005503A1/en not_active Application Discontinuation
- 1987-03-11 EP EP87902128A patent/EP0296173A1/en not_active Withdrawn
- 1987-03-11 JP JP62501993A patent/JPH01502428A/en active Pending
-
1988
- 1988-09-09 FI FI884143A patent/FI884143A0/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1003919B (en) * | 1954-10-04 | 1957-03-07 | Ernst Sieckmann | Process for the preparation of a skin care agent |
BE646095A (en) * | 1963-04-04 | 1964-10-05 | ||
CH551195A (en) * | 1969-01-23 | 1974-07-15 | Prephar | COSMETIC PREPARATIONS. |
WO1984000298A1 (en) * | 1982-07-16 | 1984-02-02 | Koezponti Valto Hitelbank | Method for producing compositions having a relaxing effect and fixed to the skin |
FR2546754A1 (en) * | 1983-06-03 | 1984-12-07 | Caola Kozmetikai | COSMETIC AGENTS FOR THE CARE OF HEALTH AND BODY |
EP0155344A2 (en) * | 1983-08-02 | 1985-09-25 | Blendax GmbH | Skin treatment composition |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042082A1 (en) * | 1998-02-23 | 1999-08-26 | Pierre Fabre Dermo-Cosmetique | Cosmetic composition comprising minor elements derived from mineral waters and chelated by plant protein hydrolysates |
FR2775185A1 (en) * | 1998-02-23 | 1999-08-27 | Fabre Pierre Dermo Cosmetique | Cosmetics containing minerals from natural water sources, chelated with vegetable protein hydrolyzates - to improve the skin, stimulate cell regeneration, and combat cutaneous aging |
Also Published As
Publication number | Publication date |
---|---|
JPH01502428A (en) | 1989-08-24 |
FI884143A (en) | 1988-09-09 |
EP0296173A1 (en) | 1988-12-28 |
FI884143A0 (en) | 1988-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cushny | Biological relations of optically isomeric substances | |
CN101697955B (en) | Eye cream with pearl hydrolyzate liposome | |
CA2297082A1 (en) | Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides | |
US4863897A (en) | Protein and mineral water-containing cosmetic compositions | |
US4837219A (en) | Medication for Alzheimer's disease | |
CA1243957A (en) | Compositions for cosmetic, health- and body- preserving use | |
CN112263503A (en) | Application of sialic acid in inhibiting melanin formation and oral whitening products | |
Bondy | Axonal transport of macromolecules I. Protein migration in the central nervous system | |
US20180177714A1 (en) | A highly concentrated seawater mineral extract and uses thereof | |
WO1987005503A1 (en) | Cosmetic compositions and process for preparing the same | |
CN1280834A (en) | Water-soluble pearl component and its preparing process | |
CN1037928C (en) | Method for prepn. of nutriment using tortoise or soft-shelled turtle | |
KR100487887B1 (en) | East extract relaxing premenstrual sydrome and menstrual pain, compositions containing the same, and preparation thereof | |
NO874656L (en) | COSMETIC PREPARATIONS AND PROCEDURES IN THEIR PREPARATION. | |
RU2299725C1 (en) | Cosmetic agent for skin care | |
HU186767B (en) | Process for producing compositions for treating dermatologicalanomalys | |
CN112438897A (en) | Skin care composition with nourishing and skin-tendering effects | |
King et al. | Cocaine and amphetamine modification of cerebral energy metabolism in vivo | |
Mathews | Physiological chemistry: a text-book and manual for students | |
RU2053763C1 (en) | Biologically active additive for cosmetic articles | |
Sunnatovna et al. | Synthesis, study of the structure and acute toxicity of the coordinating compounds of Zn (II) with succinic and pantotenic acids | |
CN112494474A (en) | Complexes containing alpha-hydroxy acids and uses thereof | |
CN112690460A (en) | Sturgeon protein peptide-containing sublingual tablet and preparation method and application thereof | |
GB2225236A (en) | Medicine for the treatment and prevention of stress and nervous disorders | |
CN112656745A (en) | Eye anti-aging nutrient solution and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): DK FI JP NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1987902128 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 884143 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1987902128 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1987902128 Country of ref document: EP |